Manuscript Submission Requirements

Manuscripts must not be under consideration for publication in another journal. Authors should ensure that their manuscript adheres to the Journal of Medicine and Urban Health (JMUH)’s guidelines before submission. JMUH recommends that authors adhere to the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals developed by the International Committee of Medical Journal Editors (ICMJE) (the latest version).

In addition, authors should prepare manuscripts in accordance with the following guidelines, as appropriate to the study design:

• CONSORT for randomized controlled trials
• STROBE for observational studies
• STARD for diagnostic accuracy studies
• TRIPOD or TRIPOD-AI for prediction model studies
• CHEERS for economic evaluation studies
• PRISMA for systematic reviews and meta-analyses
• ARRIVE for experimental animal studies
• TREND for non-randomized behavioral and public health interventions
• CARE for case reports

The corresponding author must submit the manuscript on behalf of all authors. All submissions will be screened for inappropriate use of previously published material. Manuscripts should adhere to length restrictions and be written in clear, concise English with sufficient methodological detail for reproducibility. JMUH reserves the right to edit manuscripts for grammar, style, and clarity during the editorial process.

Article Types

Manuscript Preparation

Prior to your submission, please ensure that your manuscript has been prepared according to the guidelines below.

1) Submission Method

Manuscript must be submitted through ScholarOne online submission system, which is accessible via ScholarOne Link.

2) Submission Checklist

The following checklist will be useful during the final checking of a manuscript prior to submitting it to the journal for review. Download Checklist Guideline here!

3) Cover Letter Requirements

A cover letter must include the name and title of the corresponding author, full address, telephone number, and e-mail address, as well as the title and category of the submitted manuscript (e.g., Special Article, Original Article, Systematic Reviews and Meta-Analyses, Review Article, and Case Report). The cover letter should provide a brief summary (2–3 sentences) highlighting the main findings, novelty, and clinical/scientific relevance of the work. The letter should also contain a declaration stating that the manuscript has been read and approved by all authors regarding its content and accuracy, and that the manuscript has not been previously published and is not under consideration for publication elsewhere. Finally, the cover letter must be dated and signed (handwritten or authorized electronic signature) by the corresponding author on behalf of all co-authors. Download Cover Letter to Editors here!

4) Reviewer Suggestions

We ask authors to suggest at least two potential reviewers, who possess relevant expertise and a proven publication record in the field of the submitted work, when submitting their manuscript. Opposed reviewers are optional for authors. Bear in mind any potential competing interests when making these suggestions. It is not appropriate to suggest recent collaborators or other researchers at your own institution.

5) General Formatting Requirements

• The document shall be formatted using Times New Roman, 12-point font, with double spacing and justified alignment.
• The first line of each new paragraph shall be indented using a single tab, beginning with the second paragraph under each heading.
• Page breaks or multiple returns between sections shall not be used; each section shall directly follow the preceding section on the page.
• Page numbers and continuous line numbers shall be inserted throughout the document.
• General headings (main headings) shall be presented in uppercase letters.
• Subtitles shall be presented in Title Case, with the first letter of all principal words, including the first word, capitalized, while prepositions, articles, and coordinating conjunctions shall remain in lowercase.
• Abbreviations shall be written out in full upon first use, followed by the abbreviation in parentheses. The abbreviation shall be used thereafter. Abbreviations shall not be used in titles, headings, abstracts, or references. The abbreviation lists used in the abstract and the main text shall be considered independent of each other.

6) Title Page Requirements

All manuscripts must contain a title page that includes all of the following information.

• The title of the manuscript shall be presented in sentence case and shall not contain abbreviations unless they are standard accepted.
• The running title shall not exceed 60 characters.
• The full names of all authors, all academic degrees, and the full affiliations of all authors, including their complete postal addresses, shall be provided.
• Author affiliations shall be indicated using superscript numbers.
• The corresponding author’s name and e-mail address must be included.
• The corresponding author and co-authors are strongly encouraged to register for and provide an ORCID iD. This ensures the correct attribution of professional achievements, research funding, and publication workflows. Authors may register free of charge at https://orcid.org/.

7) Manuscript Sections (original article)

Original articles must contain all of the following sections:

• Abstract: This section should be 200–350 words and must not contain any references. A structured abstract is required, consisting of four concise paragraphs under the headings: Objective(s), Materials and Methods, Results, and Conclusion(s). The Objective(s) should clearly state the purpose of the study or the hypothesis being tested. The Materials and Methods should describe the study design, study setting, subjects (including number and type), and any treatments or interventions applied. The Results should summarize the key outcomes of the study, and the Conclusion(s) should present the significant findings and their implications. Below the English abstract, authors should list 3–5 keywords for indexing purposes.
  Note: For special articles, review articles and case reports, the abstract must be no longer than 250 words, written in a single paragraph without any subheadings. Below the English abstract, authors should provide 3–5 keywords for indexing purposes.
• Introduction: This section should provide a concise background to the study, outlining what is currently known about the topic and its scientific or clinical significance. It should clearly state the rationale for the study, identify the knowledge gap, and present the study objectives and, where applicable, hypotheses. All information presented should be supported by relevant references, with citations that are current and derived from credible sources. The Introduction should conclude with a clear and explicit statement of the study aim.
• Materials and Methods: This section should provide sufficient detail to enable other researchers to replicate the study and reproduce its results. For each experiment, authors should describe all procedures performed, including the study design, instruments and equipment, reagents, experimental procedures, and analytical methods. The study population, sample, or experimental model should be clearly described, including relevant inclusion and exclusion criteria and any treatments or interventions applied. For studies involving human participants, authors should clearly state the study population, eligibility criteria, outcome measures, ethical approval, informed consent procedures, and any relevant registration information. For animal studies, authors should provide sufficient information on the species, strain, sex, age, number of animals, housing and husbandry conditions, experimental procedures, treatments or interventions, outcome measures, and humane endpoints. Approval from the relevant institutional animal care and use committee or ethics committee must be explicitly stated, and applicable animal welfare guidelines should be followed and cited. Statistical analyses should be described in sufficient detail, including the statistical methods, software used, and predefined significance threshold. Appropriate references should be provided for established or previously published methods. For randomized controlled trials and systematic reviews and meta-analyses, authors must provide the relevant protocol registration number. Furthermore, authors conducting clinical trials or other human interventional studies must register their study protocols in a publicly accessible clinical trial registry (e.g., ClinicalTrials.gov or the Thai Clinical Trials Registry) before participant enrollment.
• Results: This section should provide a clear and comprehensive presentation of the study findings. Data should be presented logically and, where appropriate, summarized in tables and figures. All tables and figures must be cited in the text. The term “significant” should be used only to describe statistically significant findings, with the corresponding p-values clearly reported. Results should be presented objectively and in a manner that directly addresses the study objectives.
• Discussion: This section should briefly summarize the key findings and interpret them in the context of existing evidence and previous research. Authors should discuss the significance and implications of the findings, compare them with relevant studies where appropriate, and identify potential explanations for similarities or differences. Strengths and limitations of the study should be clearly acknowledged, and recommendations or directions for future research may be provided where appropriate.
• Conclusion: This section should succinctly summarize the principal findings of the study and highlight their significance and relevance to the field. It should be concise, directly supported by the study findings, and avoid introducing new information or claims not presented in the main text.
• Conflict of Interest: All authors must declare any potential conflict of interest, financial or otherwise, that could influence the study or its interpretation.
• Acknowledgments: Positioned immediately before the References section, the Acknowledgments must detail all funding sources, grants, and institutional support. It should also acknowledge non-author contributors who offered technical support, language editing, or general guidance. This section must not appear on the title page or as footnotes. Authors maintain sole responsibility for the integrity and accuracy of their work. If artificial intelligence (AI) tools or third-party editing services are used to refine language, this must be disclosed in the Acknowledgments. Authors are required to verify all AI-assisted text to ensure accuracy and prevent confidentiality violations or algorithmic bias. For disclosure example: "During the preparation of this manuscript, the author(s) used [AI tool/service] solely for language editing, grammar improvement, and readability enhancement. The author(s) reviewed and edited all generated text and take full responsibility for the content, accuracy, and scientific integrity of the final published work."
• Author Contributions: Authors should provide a brief Author Contributions statement following the CRediT taxonomy, clearly indicating each author’s specific roles in the work (e.g., Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing-original draft preparation, and Writing-review & editing). Each author must be assigned at least one meaningful contribution, and shared roles should be clearly stated.
• Data Availability Statement: JMUH follows the ICMJE Recommendations for Data Sharing. All manuscripts reporting original research, systematic reviews and meta-analyses must include a Data Availability Statement in accordance with these guidelines. Authors should provide a statement describing the availability of the research data and analytic materials (e.g., code, software, or study protocols) supporting the study, including where they can be accessed and, where applicable, any conditions or restrictions on access. If the data or materials are not publicly available, authors should state the reason and indicate how qualified researchers may request access, where possible. Data sharing is subject to applicable ethical, legal, and privacy requirements.
• References: This section should be put after the main text. The citations in the text, tables, and descriptions should be listed in the order they are reference to in the text using superscript Arabic numbers without parentheses after periods, commas, and quotation marks, but before colons, and semicolons. For example, use superscript Arabic numbers after periods.¹ Use superscript Arabic numbers after commas,². Moreover, the abbreviation "et al.", place superscript Arabic outside the period et al.⁵ References should be formatted in the "Vancouver style".